Patents by Inventor Malini Viswanathan

Malini Viswanathan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20240124593
    Abstract: The disclosure relates to antibodies that bind FcRn and methods of using these antibodies.
    Type: Application
    Filed: July 6, 2023
    Publication date: April 18, 2024
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Daniel J. Sexton, Christopher TenHoor, Malini Viswanathan
  • RNA biomarkers for hereditary angioedema
    Patent number: 11884979
    Abstract: Provided herein are methods and kits for analyzing a biological sample obtained from a subject having, suspected of having, or being at risk for a disease associated with the contact activation system.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: January 30, 2024
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Daniel J. Sexton, Malini Viswanathan, Ryan Faucette, Tripti Gaur
  • Protein biomarkers for diseases associated with the contact activation system
    Patent number: 11815516
    Abstract: Provided herein are methods and kits for analyzing a biological sample obtained from a subject having, suspected of having, or being at risk for a disease associated with the contact activation system.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: November 14, 2023
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Daniel J. Sexton, Malini Viswanathan, Ryan Faucette, Tripti Gaur
  • PLASMA KALLIKREIN BINDING PROTEINS
    Publication number: 20230340150
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Application
    Filed: October 4, 2022
    Publication date: October 26, 2023
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • Antibodies which bind Fc receptors (FcRn)
    Patent number: 11739152
    Abstract: The disclosure relates to antibodies that bind FcRn and methods of using these antibodies.
    Type: Grant
    Filed: March 17, 2021
    Date of Patent: August 29, 2023
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Daniel J. Sexton, Christopher TenHoor, Malini Viswanathan
  • PLASMA KALLIKREIN BINDING PROTEINS
    Publication number: 20230112931
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Application
    Filed: June 17, 2022
    Publication date: April 13, 2023
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • Methods of detecting plasma kallikrein
    Patent number: 11505620
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: November 22, 2022
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • METABOLITE BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM
    Publication number: 20220365101
    Abstract: Provided herein are methods and kits for analyzing a biological sample obtained from a subject having, suspected of having, or being at risk for a disease associated with the contact activation system.
    Type: Application
    Filed: April 25, 2022
    Publication date: November 17, 2022
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Daniel J. Sexton, Malini Viswanathan, Ryan Faucette, Tripti Gaur
  • Nucleic acids encoding plasma kallikrein binding proteins
    Patent number: 11401346
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: August 2, 2022
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • SYSTEMS AND METHODS FOR PRODUCING COLLAGEN 7 COMPOSITIONS
    Publication number: 20220177546
    Abstract: The present disclosure provides production systems and host cells to produce collagen 7 compositions comprising recombinant collagen 7 and/or functional variants thereof. The host cells are genetically engineered to stably express rCol7 and functional variants thereof. The collagen 7 composition can be used to restore collagen 7 levels in a subject in need, and for preventing, preventing the progression of, alleviating, and delaying the on-set of a skin condition, e.g., skin wound associated with dystrophic epidermolysis bullosa (DEB).
    Type: Application
    Filed: March 27, 2020
    Publication date: June 9, 2022
    Inventors: Mark Desouza, Malini Viswanathan, Pierra-Alain Girod, Alexandre Regamey, Valerie Le Fourn, David Calabrese, John Gill, Megan Gottlieb, Amie Lundquist, Anna Tchoudakova, George Enriquez, Rahul Chelikani, Thomas Gagliardi, Tatiana Laivins, Hang Yuan
  • Metabolite biomarkers for diseases associated with the contact activation system
    Patent number: 11340237
    Abstract: Provided herein are methods and kits for analyzing a biological sample obtained from a subject having, suspected of having, or being at risk for a disease associated with the contact activation system.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: May 24, 2022
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Daniel J. Sexton, Malini Viswanathan, Ryan Faucette, Tripti Gaur
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20210309741
    Abstract: The disclosure relates to antibodies that bind FcRn and methods of using these antibodies.
    Type: Application
    Filed: March 17, 2021
    Publication date: October 7, 2021
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Christopher TenHoor, Malini Viswanathan
  • PROTEIN BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM
    Publication number: 20210285962
    Abstract: Provided herein are methods and kits for analyzing a biological sample obtained from a subject having, suspected of having, or being at risk for a disease associated with the contact activation system.
    Type: Application
    Filed: September 15, 2017
    Publication date: September 16, 2021
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan, Ryan Faucette, Tripti Gaur
  • Nucleic acids encoding anti-neonatal Fc receptor (FcRn) antibodies
    Patent number: 11014988
    Abstract: The disclosure relates to antibodies that bind FcRn and methods of using these antibodies.
    Type: Grant
    Filed: October 7, 2019
    Date of Patent: May 25, 2021
    Assignee: Dyax Corp.
    Inventors: Daniel J. Sexton, Christopher TenHoor, Malini Viswanathan
  • PLASMA KALLIKREIN BINDING PROTEINS
    Publication number: 20200109213
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Application
    Filed: May 14, 2019
    Publication date: April 9, 2020
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20200109199
    Abstract: The disclosure relates to antibodies that bind FcRn and methods of using these antibodies.
    Type: Application
    Filed: October 7, 2019
    Publication date: April 9, 2020
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Christopher TenHoor, Malini Viswanathan
  • PLASMA KALLIKREIN BINDING PROTEINS
    Publication number: 20200017602
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Application
    Filed: June 19, 2019
    Publication date: January 16, 2020
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • METABOLITE BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM
    Publication number: 20190361036
    Abstract: Provided herein are methods and kits for analyzing a biological sample obtained from a subject having, suspected of having, or being at risk for a disease associated with the contact activation system.
    Type: Application
    Filed: September 15, 2017
    Publication date: November 28, 2019
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan, Ryan Faucette, Tripti Gaur
  • Fc receptor antibodies and methods of use thereof
    Patent number: 10479834
    Abstract: The disclosure relates to antibodies that bind FcRn and methods of using these antibodies.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: November 19, 2019
    Assignee: Dyax Corp.
    Inventors: Daniel J. Sexton, Christopher TenHoor, Malini Viswanathan
  • RNA BIOMARKERS FOR HEREDITARY ANGIOEDEMA
    Publication number: 20190241961
    Abstract: Provided herein are methods and kits for analyzing a biological sample obtained from a subject having, suspected of having, or being at risk for a disease associated with the contact activation system.
    Type: Application
    Filed: September 15, 2017
    Publication date: August 8, 2019
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan, Ryan Faucette, Tripti Gaur